Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.854
-0.047 (-5.19%)
Apr 29, 2026, 2:24 PM EDT - Market open
Oncolytics Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 5.2 | 11.08 | 26.44 | 8.62 | 32.61 | Upgrade
|
| Short-Term Investments | - | - | - | 15.13 | - | Upgrade
|
| Cash & Short-Term Investments | 5.2 | 11.08 | 26.44 | 23.75 | 32.61 | Upgrade
|
| Cash Growth | -53.05% | -58.09% | 11.33% | -27.17% | 33.08% | Upgrade
|
| Other Receivables | 0.57 | 0.05 | 0.01 | 0.02 | 0.07 | Upgrade
|
| Receivables | 0.57 | 0.05 | 0.01 | 0.02 | 0.07 | Upgrade
|
| Prepaid Expenses | 1.07 | 1.31 | 2.46 | 1.25 | 2.19 | Upgrade
|
| Other Current Assets | - | - | - | 1.34 | 0.62 | Upgrade
|
| Total Current Assets | 6.84 | 12.44 | 28.91 | 26.37 | 35.48 | Upgrade
|
| Property, Plant & Equipment | 0.74 | 0.99 | 0.49 | 0.48 | 0.77 | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.74 | - | Upgrade
|
| Total Assets | 7.58 | 13.42 | 29.4 | 27.58 | 36.25 | Upgrade
|
| Accounts Payable | 3.5 | 0.76 | 0.82 | 1.66 | 0.47 | Upgrade
|
| Accrued Expenses | 2.33 | 2.57 | 1.89 | 1.03 | 1.1 | Upgrade
|
| Current Portion of Leases | 0.19 | 0.2 | 0.1 | 0.16 | 0.23 | Upgrade
|
| Other Current Liabilities | 0.08 | 1.36 | 0.4 | 0.06 | 0.32 | Upgrade
|
| Total Current Liabilities | 6.1 | 4.89 | 3.21 | 2.91 | 2.13 | Upgrade
|
| Long-Term Leases | 0.37 | 0.56 | 0.22 | 0.12 | 0.29 | Upgrade
|
| Long-Term Unearned Revenue | 4.91 | 4.68 | 5.1 | 4.97 | 5.32 | Upgrade
|
| Total Liabilities | 11.38 | 10.12 | 8.52 | 8 | 7.73 | Upgrade
|
| Common Stock | - | - | 326.29 | 298.53 | 309.25 | Upgrade
|
| Additional Paid-In Capital | 419.47 | 397.67 | 31.89 | 29.59 | 26.99 | Upgrade
|
| Retained Earnings | -429.5 | -400.74 | -337.72 | -309.03 | -310.88 | Upgrade
|
| Comprehensive Income & Other | 6.23 | 6.36 | 0.41 | 0.49 | 3.17 | Upgrade
|
| Shareholders' Equity | -3.8 | 3.3 | 20.87 | 19.58 | 28.53 | Upgrade
|
| Total Liabilities & Equity | 7.58 | 13.42 | 29.4 | 27.58 | 36.25 | Upgrade
|
| Total Debt | 0.56 | 0.76 | 0.32 | 0.28 | 0.52 | Upgrade
|
| Net Cash (Debt) | 4.64 | 10.32 | 26.12 | 23.47 | 32.09 | Upgrade
|
| Net Cash Growth | -55.04% | -60.49% | 11.27% | -26.86% | 32.67% | Upgrade
|
| Net Cash Per Share | 0.05 | 0.13 | 0.39 | 0.40 | 0.60 | Upgrade
|
| Filing Date Shares Outstanding | 116.13 | 86.42 | 75.42 | 62.83 | 57.11 | Upgrade
|
| Total Common Shares Outstanding | 108.02 | 80.02 | 74.42 | 61.33 | 55.04 | Upgrade
|
| Working Capital | 0.74 | 7.55 | 25.7 | 23.45 | 33.36 | Upgrade
|
| Book Value Per Share | -0.04 | 0.04 | 0.28 | 0.32 | 0.52 | Upgrade
|
| Tangible Book Value | -3.8 | 3.3 | 20.87 | 19.58 | 28.53 | Upgrade
|
| Tangible Book Value Per Share | -0.04 | 0.04 | 0.28 | 0.32 | 0.52 | Upgrade
|
| Machinery | 0.62 | 0.6 | 0.56 | 0.55 | 0.54 | Upgrade
|
| Leasehold Improvements | 0.13 | 0.13 | 0.17 | 0.17 | 0.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.